Literature DB >> 26346792

Stopping immunomodulatory medications in MS: Frequency, reasons and consequences.

W O Tobin1, B G Weinshenker2.   

Abstract

Prolonged periods of disease quiescence during long term treatment of patients with clinically isolated syndrome and MS may prompt consideration of discontinuing disease-modifying therapy (DMT). We reviewed pertinent studies to identify the frequency and reasons for discontinuation of DMT.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Disease activity; Multiple sclerosis; Treatment discontinuation

Mesh:

Substances:

Year:  2015        PMID: 26346792     DOI: 10.1016/j.msard.2015.07.004

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  2 in total

Review 1.  Multiple sclerosis: Is there a safe time to discontinue therapy in MS?

Authors:  Mark S Freedman
Journal:  Nat Rev Neurol       Date:  2016-12-28       Impact factor: 42.937

2.  Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment.

Authors:  José Manuel Garcia-Dominguez; Delicias Muñoz; Marta Comellas; Irmina Gonzalbo; Luis Lizán; Carlos Polanco Sánchez
Journal:  Patient Prefer Adherence       Date:  2016-09-26       Impact factor: 2.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.